Lifecare – Letter from the CEO

Bergen, Norway 5 Januar 2023

2022 was a very good year for Lifecare as a company and we welcome 2023expecting continued significant progress in our mission to make life easier forpatients with diabetes.

Throughout 2022 Lifecare disclosed several milestone events, read more in letterfrom Lifecare's CEO published today:

This is Lifecare: Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).

Further information Joacim Holter, CEO, Lifecare AS,,+47 40 05 90 40

This stock exchange announcement was published by Joacim Holter, CEO at LifecareAS, on 5.1.23 at 14:00 CET.